SCHEMBL2473324

SCHEMBL2473324

CC(=O)c1c(F)cccc1OC(=S)N(C)C

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.49
NCEH1 Q6PIU2 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
POLB P06746 3/20 0.38
RAB9A P51151 3/20 0.38
ALDH1A1 P00352 3/20 0.38
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
RECQL P46063 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
THRB P10828 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
KRAS P01116 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10735597 0.84 PPARG (0.43) KMT2ANCEH1TDP1POLBRAB9A
SCHEMBL10737045 0.83 THRB (0.52) KMT2ANCEH1ALDH1A1MAPTSMN1; SMN2
SCHEMBL13717859 0.80 KMT2A (0.57) KMT2ATDP1CES2CES1POLB
SCHEMBL3338632 0.79 SLC6A2 (0.38) KMT2ATDP1CES2CES1POLB
SCHEMBL1957640 0.75 CA9 (0.57) KMT2ACES2CES1POLBRAB9A
SCHEMBL30313283 0.75 CA9 (0.57) KMT2ACES2CES1POLBRAB9A
SCHEMBL13717296 0.75 KMT2A (0.51) KMT2ACES2CES1ALDH1A1MAPT
SCHEMBL10746424 0.75 NCEH1 (0.45) KMT2ANCEH1TDP1POLBRAB9A
SCHEMBL16387188 0.74 KMT2A (0.50) KMT2ATDP1ALDH1A1MAPTSMN1; SMN2
SCHEMBL13717981 0.74 KMT2A (0.50) KMT2ACES2CES1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2370422-B1 THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS FIBROGEN INC (US) 2019-06-05 EP disclosed
US-9149476-B2 Thiochromene derivatives as HIF hydroxylase inhibitors FIBROGEN, INC. (US) 2015-10-06 US disclosed
US-20150182528-A1 THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS FIBROGEN, INC. 2015-07-02 US disclosed
US-8927591-B2 Thiochromene derivatives as HIF hydroxylase inhibitors FIBROGEN, INC. (US) 2015-01-06 US disclosed
US-20110305776-A1 THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS FIBROGEN, INC. (US) 2011-12-15 US disclosed
CN-102272117-A Benzothiopyran derivatives as HIF hydroxylase inhibitors 2011-12-07 CN disclosed
EP-2370422-A1 THIOCHROMENE DERIVATIVES AS HIP HYDROXYLASE INHIBITORS Fibrogen, Inc. (US) 2011-10-05 EP disclosed
WO-2010056767-A1 THIOCHROMENE DERIVATIVES AS HIP HYDROXYLASE INHIBITORS FIBROGEN, INC. (US) 2010-05-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110305776-A1 THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS HIF1AN, HIF1A, EGLN2 KMT2A 681/4885NCEH1 402/4885TDP1 2259/4885
US-20150182528-A1 THIOCHROMENE DERIVATIVES AS HIF HYDROXYLASE INHIBITORS HIF1AN, HIF1A, EGLN2 KMT2A 681/4885NCEH1 402/4885TDP1 2259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.